Think Zinc: Molecular Sensor Could Reveal Zinc's Role in Diseases
News Sep 08, 2009
Scientists have developed a new molecular sensor that can reveal the amount of zinc in cells, which could tell us more about a number of diseases, including type 2 diabetes.
The research, published in Nature Methods, opens the door to the hidden world of zinc biology by giving scientists an accurate way of measuring the concentration of zinc and its location in cells for the first time.
Zinc is involved in many processes in the body and five percent of all the proteins made by the body's cells require zinc. Scientists believe that zinc plays a role in many diseases: for example, it helps package insulin in pancreas cells, and in people with type 2 diabetes, the gene that controls this packaging is often defective.
Previously, researchers used crude chemical techniques to get a rough idea of the concentration of zinc in cells. However, they could not produce an accurate picture of how much zinc was present in cells or where it was within them.
In this study, researchers from Imperial College London and Eindhoven University of Technology in The Netherlands have developed a sensor using fluorescence proteins that act as a molecular switch by changing color when they bind to zinc, showing how much zinc is present in an individual cell.
Professor Guy Rutter, one of the authors of the study from the Division of Medicine at Imperial College London, said: "There has been relatively little biological work done on zinc compared to other metals such as calcium and sodium, partly because we didn't have the tools to measure it accurately before now. Zinc is so important in the body - studies have suggested it has roles in many different areas, including muscles and the brain."
The new sensor, called a fluorescence resonance energy transfer (FRET)-based sensor, is made up of two color variants of a green fluorescent protein from jellyfish. The researchers altered the first variant to give off light at a certain wavelength, and altered the second variant to collect that light.
When the proteins attached to zinc ions, they became pushed apart and the transfer of light between them became weaker. The researchers used a fluorescence microscope to detect the wavelengths of light emitted by the proteins. This revealed zinc in the cell, with colored patches visible where the proteins detected zinc.
The researchers used their new sensor to look for zinc in pancreatic cells, where insulin is packaged around zinc ions. Previous research had suggested that in people with type 2 diabetes, the gene that controls the packaging process is often defective, affecting the way insulin is stored. The researchers found a high concentration of zinc ions inside certain parts of the cells where insulin is found. They hope their new sensor could help scientists look more closely at this to find out exactly how zinc is involved in diabetes.
"We can now measure very accurately the concentration of zinc in cells and we can also look at where it is inside the cell, using our molecular measuring device. This sort of information will help us to see what is going on inside different tissues, for example in the brain in Alzheimer's disease, where we also suspect zinc may be involved. We hope this new sensor will help researchers learn more about zinc-related diseases and potentially identify new ways of treating them," added Professor Rutter.
The researchers would now like to develop their new sensor to look at zinc in a living mouse model, so they can observe the movement of zinc in different tissues, for example in diabetes.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.